R. Hultcrantz

3.6k total citations · 1 hit paper
62 papers, 2.6k citations indexed

About

R. Hultcrantz is a scholar working on Hepatology, Epidemiology and Hematology. According to data from OpenAlex, R. Hultcrantz has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 26 papers in Epidemiology and 12 papers in Hematology. Recurrent topics in R. Hultcrantz's work include Liver Disease Diagnosis and Treatment (19 papers), Liver Diseases and Immunity (18 papers) and Iron Metabolism and Disorders (11 papers). R. Hultcrantz is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Liver Diseases and Immunity (18 papers) and Iron Metabolism and Disorders (11 papers). R. Hultcrantz collaborates with scholars based in Sweden, United Kingdom and United States. R. Hultcrantz's co-authors include Ulrika Broomé, Greger Lindberg, Hans Glaumann, Rolf Olsson, Lars Lööf, Hanne Prytz, Hanna Sandberg–Gertzén, Anna Danielsson, Susanna M. Wallerstedt and G. Bodemar and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Gut.

In The Last Decade

R. Hultcrantz

61 papers receiving 2.5k citations

Hit Papers

Natural history and prognostic factors in 305 Swedish pat... 1996 2026 2006 2016 1996 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
    1996 578 citations Ulrika Broomé, Rolf Olsson et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Hultcrantz Sweden 26 1.1k 1.1k 904 608 480 62 2.6k
Lionel Rabin United States 19 932 0.8× 902 0.8× 853 0.9× 306 0.5× 686 1.4× 30 2.4k
J. Ludwig United States 26 2.0k 1.8× 2.0k 1.8× 1.0k 1.1× 483 0.8× 310 0.6× 55 3.3k
Ivo Graziadei Austria 35 3.2k 2.8× 2.1k 1.9× 1.8k 2.0× 659 1.1× 575 1.2× 97 4.8k
Urmila Khettry United States 27 1.1k 1.0× 1.1k 1.1× 1.1k 1.2× 266 0.4× 314 0.7× 76 2.8k
Deborah K. Freese United States 30 1.4k 1.2× 1.1k 1.0× 2.1k 2.3× 443 0.7× 396 0.8× 74 3.3k
Hirofumi Kawanaka Japan 32 1.6k 1.4× 1.2k 1.1× 1.6k 1.8× 445 0.7× 327 0.7× 176 3.1k
Kristian Bjøro Norway 27 1.6k 1.4× 1.9k 1.8× 592 0.7× 274 0.5× 133 0.3× 79 3.0k
Arnaud Lemmers Belgium 22 510 0.4× 881 0.8× 874 1.0× 707 1.2× 425 0.9× 76 2.3k
Archana Rastogi India 28 1.2k 1.1× 1.2k 1.1× 679 0.8× 262 0.4× 332 0.7× 168 2.5k
Hiroto Egawa Japan 30 1.8k 1.6× 1.1k 1.0× 1.6k 1.8× 174 0.3× 286 0.6× 118 3.0k

Countries citing papers authored by R. Hultcrantz

Since Specialization
Citations

This map shows the geographic impact of R. Hultcrantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hultcrantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hultcrantz more than expected).

Fields of papers citing papers by R. Hultcrantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hultcrantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hultcrantz. The network helps show where R. Hultcrantz may publish in the future.

Co-authorship network of co-authors of R. Hultcrantz

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hultcrantz. A scholar is included among the top collaborators of R. Hultcrantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hultcrantz. R. Hultcrantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lindström, Linda S., Kirsten Muri Boberg, Ola Wikman, et al.. (2012). High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Alimentary Pharmacology & Therapeutics. 35(4). 451–457. 58 indexed citations
2.
Kotronen, Anna, Jukka Westerbacka, BA Fielding, et al.. (2010). Splanchnic balance of free fatty acids, endocannabinoids and lipids in subjects with NAFLD. Diabetologia. 53.
3.
Ahlberg, Gunnel, R. Hultcrantz, Edgar Jaramillo, Annika Lindblom, & Dag Arvidsson. (2005). Virtual Reality Colonoscopy Simulation: A Compulsory Practice for the Future Colonoscopist?. Endoscopy. 37(12). 1198–1204. 115 indexed citations
4.
Waßmuth, Ralf, Anna Danielsson, R. Hultcrantz, et al.. (2002). HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens. 59(5). 381–387. 30 indexed citations
5.
Cardoso, Elsa M., et al.. (2001). Hepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli. European Journal of Clinical Investigation. 31(1). 45–53. 31 indexed citations
6.
Reichard, Olle, et al.. (2000). Long-term follow-up of patients notified with non-A non-B hepatitis in Sweden (1979–84). Journal of Hepatology. 32. 107–107. 4 indexed citations
7.
Harper, Pauline, et al.. (1998). [Porphyria cutanea tarda is the most common type of porphyria. Medical control is a team work].. PubMed. 95(28-29). 3195–9. 2 indexed citations
8.
Harper, Pauline, et al.. (1998). [Risk of liver failure in erythropoietic protoporphyria. Be alert for sings of cholestatic development!].. PubMed. 95(26-27). 3051–6. 2 indexed citations
9.
Grünewald, Johan, et al.. (1997). Preferential Vβ3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. Journal of Hepatology. 26(3). 527–534. 33 indexed citations
10.
Broomé, Ulrika, Rolf Olsson, Lars Lööf, et al.. (1996). Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.. Gut. 38(4). 610–615. 578 indexed citations breakdown →
11.
Löfberg, Robert, Åke Danielsson, Ole B. Suhr, et al.. (1996). Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology. 110(6). 1713–1718. 136 indexed citations
12.
Olerup, Olle, Rolf Olsson, R. Hultcrantz, & Ulrika Broomé. (1995). HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology. 108(3). 870–878. 72 indexed citations
13.
Hultcrantz, R., Ulrika Broomé, Gunnar Järnerot, et al.. (1995). CA 19-9, CA50 and CA242 as tools for diagnosis of cholangiocarcinoma (CC) in patients with primary sclerosing cholangitis (PSC).. Scandinavian Journal of Gastroenterology. 30. 34. 4 indexed citations
14.
Broomé, Ulrika, et al.. (1994). Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.. Gut. 35(1). 84–89. 107 indexed citations
15.
Bülow, S, Kay Neale, Heikki Järvinen, et al.. (1992). Rectal cancer risk in patients treated for familial adenomatous polyposis. British journal of surgery. 79(12). 1372–1375. 96 indexed citations
16.
Broomé, Ulrika, Hans Glaumann, R. Hultcrantz, & Urban Forsum. (1990). Distribution of HLA-DR, HLA-DP, HLA-DQ Antigens in Liver Tissue from Patients with Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology. 25(1). 54–58. 53 indexed citations
17.
Broomé, Ulrika, Hans Glaumann, & R. Hultcrantz. (1990). Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests.. Gut. 31(4). 468–472. 25 indexed citations
18.
Berglund, Lars, Bo Angelin, R. Hultcrantz, et al.. (1990). Studies with the haeme oxygenase inhibitor Sn-protoporphyrin in patients with primary biliary cirrhosis and idiopathic haemochromatosis.. Gut. 31(8). 899–904. 18 indexed citations
19.
Hultcrantz, R., et al.. (1989). The source of serum alkaline phosphatases in liver‐tumour‐bearing rats. Liver International. 9(4). 216–222. 1 indexed citations
20.
Thulin, L, Gunnar Tydén, Björn Nyberg, Berit Calissendorff, & R. Hultcrantz. (1986). Reduction of hepatic arterial flow by degradable microspheres in patients with liver tumor.. PubMed. 152. 447–51. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lionel Rabin Breakdown of academic impact, for papers by J. Ludwig Breakdown of academic impact, for papers by Ivo Graziadei Breakdown of academic impact, for papers by Urmila Khettry Breakdown of academic impact, for papers by Deborah K. Freese Breakdown of academic impact, for papers by Hirofumi Kawanaka Breakdown of academic impact, for papers by Kristian Bjøro Breakdown of academic impact, for papers by Arnaud Lemmers Breakdown of academic impact, for papers by Archana Rastogi Breakdown of academic impact, for papers by Hiroto Egawa
Rankless by CCL
2026